VRTX — Vertex Pharmaceuticals Inc

AI Signal & Stock Analysis · Strong ↑

As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for VRTX is Strong ↑; the stock is at $506.71 (-1.88% today); neutral (RSI 56); technical trend is Raise; news sentiment is nan.

Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.

Key metrics

What's driving the signal

• RSI is neutral
• Relative volume 0.25× (light)
• Technical trend is Raise
• News sentiment is nan
• 7% below its 52-week high
• 35% above its 52-week low

Frequently asked about VRTX

What is AkshayaAI's signal for VRTX today?

As of Aug 14 2026, 1:04 PM, AkshayaAI assigns VRTX (Vertex Pharmaceuticals Inc) a Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.

Is VRTX overbought or oversold right now?

VRTX's RSI is neutral (RSI 56). A reading above 70 is typically considered overbought and below 30 oversold.

Where is VRTX in its 52-week range?

VRTX is trading about 7% below its 52-week high and 35% above its 52-week low as of Aug 14 2026, 1:04 PM.

When is VRTX's next earnings date?

VRTX's next earnings date is 8/3/2026 4:30:00 PM.

What sector is VRTX in?

VRTX is classified under Healthcare-Biotech in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.